APO-EPLERENONE eplerenone 25 mg tablet blister pack Australien - engelska - Department of Health (Therapeutic Goods Administration)

apo-eplerenone eplerenone 25 mg tablet blister pack

arrotex pharmaceuticals pty ltd - eplerenone, quantity: 25 mg - tablet, film coated - excipient ingredients: titanium dioxide; hypromellose; croscarmellose sodium; magnesium stearate; iron oxide yellow; microcrystalline cellulose; iron oxide red; purified talc; lactose monohydrate; macrogol 6000 - eplerenone is indicated to reduce the risk of: - cardiovascular death in combination with standard therapy in patients who have evidence of heart failure and left ventricular impairment within 3?14 days of an acute myocardial infarction (see clinical trials and dosage and administration). - cardiovascular mortality and morbidity in adult patients with nyha class ii (chronic) heart failure and left ventricular systolic dysfunction (lvef ? 30% or lvef ? 35% in addition to qrs duration of > 130 msec), in addition to standard optimal therapy (see clinical trials).

APO-EPLERENONE eplerenone 50 mg tablet blister pack Australien - engelska - Department of Health (Therapeutic Goods Administration)

apo-eplerenone eplerenone 50 mg tablet blister pack

arrotex pharmaceuticals pty ltd - eplerenone, quantity: 50 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; microcrystalline cellulose; iron oxide yellow; titanium dioxide; lactose monohydrate; macrogol 6000; hypromellose; purified talc; magnesium stearate; iron oxide red - eplerenone is indicated to reduce the risk of: - cardiovascular death in combination with standard therapy in patients who have evidence of heart failure and left ventricular impairment within 3?14 days of an acute myocardial infarction (see clinical trials and dosage and administration). - cardiovascular mortality and morbidity in adult patients with nyha class ii (chronic) heart failure and left ventricular systolic dysfunction (lvef ? 30% or lvef ? 35% in addition to qrs duration of > 130 msec), in addition to standard optimal therapy (see clinical trials).

INSPRA 50 Milligram Film Coated Tablet Irland - engelska - HPRA (Health Products Regulatory Authority)

inspra 50 milligram film coated tablet

pco manufacturing - eplerenone - film coated tablet - 50 milligram - aldosterone antagonists

INSPRA 25 Milligram Film Coated Tablet Irland - engelska - HPRA (Health Products Regulatory Authority)

inspra 25 milligram film coated tablet

pco manufacturing - eplerenone - film coated tablet - 25 milligram - aldosterone antagonists

Eplerenone Bluefish 25 mg film-coated tablets Irland - engelska - HPRA (Health Products Regulatory Authority)

eplerenone bluefish 25 mg film-coated tablets

bluefish pharmaceuticals ab - eplerenone - film-coated tablet - 25 milligram(s) - aldosterone antagonists; eplerenone

Eplerenone Bluefish 50 mg film-coated tablets Irland - engelska - HPRA (Health Products Regulatory Authority)

eplerenone bluefish 50 mg film-coated tablets

bluefish pharmaceuticals ab - eplerenone - film-coated tablet - 50 milligram(s) - aldosterone antagonists; eplerenone

Eplerenone Mylan 25 mg film-coated tablets Irland - engelska - HPRA (Health Products Regulatory Authority)

eplerenone mylan 25 mg film-coated tablets

mcdermott laboratories ltd., t/a gerard laboratories - eplerenone - film-coated tablet - 25 milligram(s) - aldosterone antagonists; eplerenone

Eplerenone Mylan 50 mg film-coated tablets Irland - engelska - HPRA (Health Products Regulatory Authority)

eplerenone mylan 50 mg film-coated tablets

mcdermott laboratories ltd t/a gerard laboratories - eplerenone - film-coated tablet - 50 milligram(s) - aldosterone antagonists; eplerenone

PREXUM COMBI LD 2.5/0.625 perindopril arginine 2.5mg / indapamide hemihydrate 0.625mg film-coated tablet bottle Australien - engelska - Department of Health (Therapeutic Goods Administration)

prexum combi ld 2.5/0.625 perindopril arginine 2.5mg / indapamide hemihydrate 0.625mg film-coated tablet bottle

servier laboratories (aust) pty ltd - indapamide hemihydrate, quantity: 0.625 mg; perindopril arginine, quantity: 2.5 mg - tablet, film coated - excipient ingredients: sodium starch glycollate type a; maltodextrin; magnesium stearate; colloidal anhydrous silica; macrogol 6000; lactose monohydrate; colour - treatment of hypertension.

COVERSYL PLUS 5/1.25 perindopril arginine 5mg and indapamide hemihydrate 1.25 mg film-coated tablet bottle Australien - engelska - Department of Health (Therapeutic Goods Administration)

coversyl plus 5/1.25 perindopril arginine 5mg and indapamide hemihydrate 1.25 mg film-coated tablet bottle

servier laboratories (aust) pty ltd - perindopril arginine, quantity: 5 mg; indapamide hemihydrate, quantity: 1.25 mg - tablet, film coated - excipient ingredients: magnesium stearate; macrogol 6000; maltodextrin; sodium starch glycollate type a; colloidal anhydrous silica; lactose monohydrate; colour - treatment of hypertension. treatment should not be initiated with this combination.